Lupin LimitedNSE: LUPIN

Press Release Nov 04 2021

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-04-2021-2

Lupin Limited has informed the Exchange regarding a press release dated November 04, 2021, titled "Lupin s Namuscla�� (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases